Clinical Trial

Phenotype Guided Vasoactive Medication During Kidney Transplantation

Name: Phenotype Guided Vasoactive Medication During Kidney Transplantation — clinical trial record (NCT07633600)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.

Trial Details

NCT Number	NCT07633600
Lead Sponsor	Jennifer Cutler
Conditions	Kidney Transplant, Fluid Management
Enrollment	255 participants
Start Date	2026-06-01
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-08